iBio (IBIO) announced that iBio’s common stock has been approved for listing on Nasdaq and iBio will transfer its stock exchange listing to Nasdaq from the NYSE American.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBIO:
- iBio Announces Transfer to Nasdaq Capital Market
- Ibio Inc Faces Financial Risk from Potential Stockholder Equity Dilution and Capital Raising Challenges
- iBio files to sell 246K shares of common stock for holders
- Biotech Alert: Searches spiking for these stocks today
- Closing Bell Movers: KB Home jumps 7% after Q4 earnings beat